Live Breaking News & Updates on Markets amp regulations

Stay informed with the latest breaking news from Markets amp regulations on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Markets amp regulations and stay connected to the pulse of your community

University of Dundee spin-out bags £4m to develop active biologic drugs

UK-based biotech Glen Clova Scientific has raised £4 million in seed financing to develop a pipeline of a new generation of active biologic drugs.

United-kingdom , Glen-clova , Angus , Scotland , Moray-martin , Steven-powell , John-foerster , Patricia-reynolds , Doug-quinn , University-of-dundee , Norcliffe-capital , Glen-clova-scientific

Inizio Engage: Elevating healthcare product launches through smart data

A recent Deloitte report revealed that 36% of healthcare product launches fell short of achieving 80% of their sales targets within the first two years.

Sese-abhulimen , Maya-martinez-davis , Mike-stout , Deloitte , Inizio-engage , Reuters-pharma-united-states , Bio-pharma , Pharma-united-states , Markets-amp-regulations , Ealthcare , Ata-management , Ealth-equity

AstraZeneca's Lynparza to remain dominant in PARP inhibitors market

Back in 2014, AstraZeneca and Merck were the first to receive FDA approval for their PARP inhibitor Lynparza (olaparib) for use in breast cancer gene (BRCA)-mutated metastatic ovarian cancer patients.

Johnson-zytiga , Biswajit-podder , Astrazeneca , Markets-amp-regulations , Ipelines , Merging-markets , Strazeneca , Arp-inhibitor , Ncology , Linical-trials ,

WuXi AppTec strongly denies sharing clients' data with Beijing

Wuxi AppTec says recent allegations made by the US government that it has shared clients' data with Beijing without consent are ‘misleading’ and ‘inaccurate’.

National-intelligence , Reuters , Congress-on , Wuxi-apptec , State-department , Complete-genomics , Markets-amp-regulations , Ontract-manufacturing-amp-logistics , Elivery-technologies , Ontract-manufacturing , Ontract-sales-amp-marketing

Platform integrates formulation development and on-demand GMP manufacturing

At CPhI North America, Quotient Sciences is looking forward to reconnecting with its customers and giving them a preview of how we are looking to expand Translational Pharmaceutics further within the US.

Pennsylvania , United-states , United-kingdom , Nottingham , Philadelphia , Ma-cdmos-cros , Pennsylvania-convention-center , Quotient-sciences , Charles-river-laboratories , Charles-river , Translational-pharmaceutics

FDA approves Takeda's self-administered Entyvio for Crohn's disease

Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) version of Entyvio, its treatment for adults with moderate to severe Crohn’s disease (CD).

Timothy-ritter , Gi-alliance-research , School-of-medicine , Brandon-monk , Business-unit , Entyvio-pen , Markets-amp-regulations , Akeda , Rohn-039s-disease , Da , Linical-trial ,

Hospitalized incident cases of MRSA to reach 791,000 in 2033

According to data and analytics firm GlobalData, the burden of hospitalized incident cases of methicillin-resistant Staphylococcus aureus (MRSA) is set to grow from 714,000 to 791,000 cases by 2023.

France , Spain , Italy , Japan , Germany , United-kingdom , Anna-moody , Moody , Markets-amp-regulations , Merging-markets , Rsa , Ospital

SK pharmteco to manufacture Ferring Pharmaceuticals' gene therapy

SK pharmteco has signed an agreement with Ferring Pharmaceuticals, to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical gene therapy Adstiladrin.

New-jersey , United-states , Finland , Parsippany , Bipin-dalmia , Joerg-ahlgrimm , Drug-administration , Ferring-pharmaceuticals , World-bladder-cancer-patient-coalition , Bacillus-calmette-gu , Markets-amp-regulations , Ipelines

Selkirk Pharma: Adapting to regulatory shifts and market demand

Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.

Supply-chain , Digital-transformation-plan , Markets-amp-regulations , Io-developments , Iopharma-culture , Ipelines , Merging-markets , Mo , Ontract-manufacturing , Anufacturing , Upply-chain

Piramal Pharma unveils expanded services and growth vision

What is ADC specialist Piramal Pharma planning for the upcoming CPHI North America conference? We sat down with chief commercial officer Stuart Needleman to find out what's on the company's agenda.

Canada , Pennsylvania , United-states , Grangemouth , Falkirk , United-kingdom , Scotland , Piramal-pharma-solutions-science , Piramal-pharma-solutions , North-america , Pharma-solutions